Navalign LLC’s Elevance Health ELV Stock Holding History

Navalign LLC’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-128	Closed	-$44.9K	–	222
2025 Q4	$44.9K	Buy	+128	New	+$43.3K	0.01%	202
2023 Q4	–	Sell	-516	Closed	-$225K	–	131
2023 Q3	$225K	Buy	+516	New	+$234K	0.09%	130

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Navalign LLC's ELV Position: Q1 2026 in Review

Navalign LLC sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 128 shares — an estimated $44.9K sold.

Navalign LLC first reported a position in ELV in Q3 2023 and held it in 2 quarters. The position peaked at $225K in Q3 2023. 1,466 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Navalign LLC reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
Navalign LLC sold 128 Elevance Health shares in Q1 2026, an estimated $44.9K.
Navalign LLC first reported a position in Elevance Health in Q3 2023 and held it in 2 quarters.
Navalign LLC's Elevance Health position peaked at $225K in Q3 2023.
1,466 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.